Compare IMUX & MMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMUX | MMTX |
|---|---|---|
| Founded | 2016 | 2025 |
| Country | United States | Taiwan |
| Employees | 66 | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 88.1M |
| IPO Year | 2013 | N/A |
| Metric | IMUX | MMTX |
|---|---|---|
| Price | $1.19 | $9.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 490.0 |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $139.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $9.89 |
| 52 Week High | $1.51 | $10.02 |
| Indicator | IMUX | MMTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 58.53 |
| Support Level | $0.64 | $9.90 |
| Resistance Level | $1.51 | $10.02 |
| Average True Range (ATR) | 0.12 | 0.01 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 27.78 | 42.86 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Miluna Acquisition Corp is a blank check company.